Patents by Inventor Gerhard Jaehne

Gerhard Jaehne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel adenosine analogues and their use as pharmaceutical agents
    Publication number: 20040127434
    Abstract: The present invention relates to compounds according to the general formula (I) 1
    Type: Application
    Filed: June 27, 2003
    Publication date: July 1, 2004
    Inventors: Antony Bigot, Siegfried Stengelin, Gerhard Jaehne, Andreas Herling, Guenter Mueller, Franz Jakob Hock, Michael R. Myers
  • Use of IkappaB-kinase inhibitors in pain therapy
    Publication number: 20040116494
    Abstract: The present invention relates to the use of I&kgr;B-kinase Inhibitors and methods for the prophylaxis and therapy for treating pain comprising administering such compounds.
    Type: Application
    Filed: August 18, 2003
    Publication date: June 17, 2004
    Applicant: AVENTIS PHARMA DEUTSCHLAND GMBH
    Inventors: Martin Michaelis, Olaf Ritzeler, Gerhard Jaehne, Karl Rudolphi, Gerd Geisslinger, Hans-Georg Schaible
  • Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
    Publication number: 20040106583
    Abstract: Polysubstituted indan-1-ol compounds of formula I, its physiologically acceptable salts and physiologically functional derivatives are disclosed 1
    Type: Application
    Filed: October 27, 2003
    Publication date: June 3, 2004
    Applicant: Aventis Pharma Deutschland GmBH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity
    Publication number: 20040092748
    Abstract: Derivatives of C2-substituted indan-1-ol compounds of formula I: 1
    Type: Application
    Filed: October 27, 2003
    Publication date: May 13, 2004
    Applicant: Aventis Pharma Deutschland GmBH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Polysubstituted indan-1-ol compounds, and methods for their preparation and use
    Publication number: 20040092489
    Abstract: Polysubstituted indan-1-ol compounds, methods for their preparation; and methods for their use are disclosed herein.
    Type: Application
    Filed: October 27, 2003
    Publication date: May 13, 2004
    Applicant: Aventis Pharma Deutschland GmBH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
    Publication number: 20040092488
    Abstract: Polysubstituted indan-1-ol compounds of formula I, its physiologically acceptable salts and physiologically functional derivatives are disclosed 1
    Type: Application
    Filed: October 27, 2003
    Publication date: May 13, 2004
    Applicant: Aventis Pharma Deutschland GmBH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Polysubstituted idan-1-ol compounds, and methods for their preparation and use
    Publication number: 20040092749
    Abstract: Polysubstituted indan-1-ol compounds, methods for their preparation; and methods for their use are disclosed herein.
    Type: Application
    Filed: October 27, 2003
    Publication date: May 13, 2004
    Applicant: Aventis Pharma Deutschland GmBH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
    Publication number: 20040082561
    Abstract: One embodiment of the invention relates to compounds of the formula I, 1
    Type: Application
    Filed: June 18, 2003
    Publication date: April 29, 2004
    Inventors: Gerhard Jaehne, Wendelin Frick, Stefanie Flohr, Andreas Lindenschmidt, Heiner Glombik, Werner Kramer, Hubert Heuer, Hans-Ludwig Schaefer
  • Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
    Publication number: 20040077623
    Abstract: One embodiment of the invention relates to compounds of the formula I, 1
    Type: Application
    Filed: June 18, 2003
    Publication date: April 22, 2004
    Inventors: Gerhard Jaehne, Wendelin Frick, Stefanie Flohr, Andreas Lindenschmidt, Heiner Glombik, Werner Kramer, Hubert Heuer, Hans-Ludwig Schaefer
  • C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
    Publication number: 20040068016
    Abstract: Embodiments of the invention relate to C2-substituted indan-1-ols and to their physiologically acceptable salts and physiologically functional derivatives.
    Type: Application
    Filed: September 22, 2003
    Publication date: April 8, 2004
    Applicant: AVENTIS PHARMA DEUTSCHLAND GMBH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
    Publication number: 20040067913
    Abstract: One embodiment of the invention relates to compounds of the formula I: 1
    Type: Application
    Filed: June 18, 2003
    Publication date: April 8, 2004
    Inventors: Gerhard Jaehne, Wendelin Frick, Stefanie Flohr, Andreas Lindenschmidt, Heiner Glombik, Werner Kramer, Hubert Heuer, Hans-Ludwig Schaefer
  • Derivatives of C2-substituted indan-1-ol compounds, methods for their preparation and use
    Patent number: 6717008
    Abstract: Derivatives of C2-substituted indan-1-ol compounds, processes for their preparation and their use are disclosed. In particular, the invention relates to compounds of the formula I and to their physiologically acceptable salts and physiologically functional derivatives. The compounds are suitable, for example, for use as anorectics.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: April 6, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use
    Patent number: 6703386
    Abstract: Compounds of the formula I, for example, are disclosed, in which R1, R2, R3, R4, R5, and R6 independently of one another are (C0-C30)-alkylene-L or are the meanings given in the description, and where L is shown connected to (C0-C30)-alkylene as follows: where Rx, Ry, Rz have the meanings given in the description, and their physiologically acceptable salts. The compounds are suitable for use, for example, as hypolipidemics.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: March 9, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Heiner Glombik, Werner Kramer, Stefanie Flohr, Wendelin Frick, Hubert Heuer, Gerhard Jaehne, Andreas Lindenschmidt, Hans-Ludwig Schaefer
  • Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
    Patent number: 6686397
    Abstract: Polysubstituted indan-1-ol compounds of formula I, its physiologically acceptable salts and physiologically functional derivatives are disclosed: Compositions comprising the same, methods of preparation and methods for the prophylaxis or treatment of obesity are also disclosed herein.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: February 3, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Polysubstituted indan-1-ol compounds, and methods for their preparation and use
    Patent number: 6670401
    Abstract: Polysubstituted indan-1-ol compounds, methods for their preparation; and methods for their use are disclosed herein. In particular, the invention relates to polysubstituted indan-1-ol compounds of the formula I and their physiologically acceptable salts. The compounds are useful, for example, as anorectics.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: December 30, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity
    Patent number: 6667345
    Abstract: Derivatives of C2-substituted indan-1-ol compounds of the formula I: its physiologically acceptable salts, and its physiologically functional derivatives for the prophylaxis or treatment of obesity are disclosed herein. Compositions comprising the same, methods for preparing the instant compounds, and methods for reducing weight in mammals and for the prophylaxis or treatment of obesity are also described.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: December 23, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
    Patent number: 6657086
    Abstract: Embodiments of the invention relate to C2-substituted indan-1-ols and to their physiologically acceptable salts and physiologically functional derivatives. Compounds of embodiments of the invention may include compounds of formula I in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable, for example, for use as anorectics.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: December 2, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals
    Publication number: 20030181491
    Abstract: The present invention is directed to C2-disubstituted indan-1-ol systems of the Formula I, 1
    Type: Application
    Filed: August 29, 2002
    Publication date: September 25, 2003
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Methods of treating insulin resistance syndrome and diabetes
    Publication number: 20030176390
    Abstract: This invention is directed to methods of treating insulin resistance syndrome and diabetes in a patient in need thereof, comprising administering to said patient a pharmaceutically effective amount of a compound derived from adenosine and analogues thereof, or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable prodrug thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof, or a pharmaceutical composition comprising such compound.
    Type: Application
    Filed: May 14, 2002
    Publication date: September 18, 2003
    Inventors: Andreas Herling, Gerhard Jaehne, Martin P. Maguire, Alfred P. Spada, Michael R. Myers, Yong Mi Choi-Sledeski, Heinz W. Pauls, William R. Ewing
  • C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
    Publication number: 20030153609
    Abstract: The present invention is directed C2-disubstituted indan-1-ones of the Formula I, 1
    Type: Application
    Filed: August 29, 2002
    Publication date: August 14, 2003
    Applicant: Aventis Pharma Dutschlan GmbH.
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel